title: Progression of parkinsonism and loss of cognitive function in Alzheimer disease.
abstract: OBJECTIVE
  To assess the relation between parkinsonism and cognitive function in Alzheimer disease from cross-sectional and longitudinal perspectives.
  
  
  METHODS
  Prospective cohort study with annual clinical evaluations during a 4-year period.
  
  
  METHODS
  Alzheimer disease clinic in an urban medical center.
  
  
  METHODS
  Four hundred ten persons with clinically diagnosed Alzheimer disease.
  
  
  METHODS
  Global and specific measures of cognitive function and parkinsonism.
  
  
  RESULTS
  Higher levels of parkinsonism at baseline were reliably associated with lower levels of cognitive function at baseline and with more rapid cognitive decline during the 4-year study period. However, the associations were small, with baseline parkinsonism accounting for less than 10% of the variation either in baseline cognitive function or in the rate of cognitive decline. By contrast, rates of change in parkinsonism and cognitive function were strongly correlated, with 70% or more shared variance in the rates of change in many models. The association was observed with diverse measures of cognition and parkinsonism and was not explained by demographic variables or use of neuroleptic medications.
  
  
  CONCLUSIONS
  In Alzheimer disease, progressive worsening of parkinsonism is more strongly associated with cognitive decline than previously recognized. Arch Neurol. 2000.
authors.affiliation: Rush Alzheimer's Disease Center, 1645 W Jackson Blvd, Suite 675, Chicago, IL 60612, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Wilson
authors.forename: D A
authors.initials: DA
authors.lastname: Bennett
authors.forename: D W
authors.initials: DW
authors.lastname: Gilley
authors.forename: L A
authors.initials: LA
authors.lastname: Beckett
authors.forename: J A
authors.initials: JA
authors.lastname: Schneider
authors.forename: D A
authors.initials: DA
authors.lastname: Evans
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000503:physiopathology* / Q000523:psychology*; D003072:Cognition Disorders / Q000150:complications* / Q000523:psychology; D003430:Cross-Sectional Studies; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D009483:Neuropsychological Tests; D010300:Parkinson Disease / Q000150:complications* / Q000503:physiopathology; D011446:Prospective Studies; D014505:Urban Population